P1608: REAL-WORLD INSIGHTS ON THE MANAGEMENT OF IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP) WITH CAPLACIZUMAB IN BELGIUM

• Daan Dierickx,
• Thierry Connerotte,
• Julie Dallemagne,
• Ann De Becker,
• Ine Moors,
• Sylvia Snauwaert,
• Anne Sonet,
• Koen Theunissen,
• Dimitri Breems,
• Bernard De Prijck,
• Aurélie Jaspers,
• Catherine Lambert,
• Bert Heyrman,
• Joris Hautekiet,
• Sofie Lyna,
• Chantal Maertens,
• Vanessa Delrieu

Affiliations

Daan Dierickx

1 University Hospitals Leuven, Department of Hematology, Leuven, Belgium

Thierry Connerotte

2 Clinique Saint Pierre, Oncology-Haematology Unit, Ottignies, Belgium

Julie Dallemagne

3 Erasme Hospital, Hematology Department, Brussels, Belgium

Ann De Becker

4 Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Hematology, Brussels, Belgium

Ine Moors

5 University Hospital Ghent, Ghent, Belgium

Sylvia Snauwaert

6 AZ Sint-Jan, Department of Hematology, Brugge, Belgium

Anne Sonet

7 CHU UCL Namur Site Godinne, Yvoir, Belgium

Koen Theunissen

8 Jessa Hospital, Department Hematology, Hasselt, Belgium

Dimitri Breems

9 Ziekenhuis Netwerk Antwerpen (ZNA), Department of Haematology, Antwerp, Belgium

Bernard De Prijck

10 Centre Hospitalier Universitaire de Liège, Department of Clinical Hematology, Liège, Belgium

Aurélie Jaspers

11 CHR Citadelle, Department of Hematology, Liège, Belgium

Catherine Lambert

12 Cliniques Universitaires Saint-Luc, Department of Hematology, Brussels, Belgium

Bert Heyrman

9 Ziekenhuis Netwerk Antwerpen (ZNA), Department of Haematology, Antwerp, Belgium

Joris Hautekiet

13 IQVIA Belux, Zaventem, Belgium

Sofie Lyna

14 Sanofi, Diegem, Belgium

Chantal Maertens

14 Sanofi, Diegem, Belgium

Vanessa Delrieu

15 Hôpital de Jolimont, Department of Hematology, La Louvière, Belgium